{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:41:41Z","timestamp":1793191301969,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leishmaniases are neglected tropical diseases of public health concern in Algeria. The immunocompromised patients with HIV, autoimmune diseases, or chronic alcohol abuse are at a higher risk of leishmaniasis. Herein, we present the case of an immunocompetent diabetic patient infected by <jats:italic>Leishmania major<\/jats:italic>, leading to life-threatening consequences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An Algerian diabetic patient developed a cutaneous lesion with large polymorphous inflamed granuloma and pyoderma gangrenosum in the left foot, following <jats:italic>L. major<\/jats:italic> infection. A delayed follow-up led to a treatment failure, resulting in the amputation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This report highlights the absence of timely treatment of <jats:italic>Leishmania<\/jats:italic> infection as a life-threatening point among high-risk diabetic patients. Clinicians should be aware of this parasitosis leading to severe complications in diabetic patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06909-8","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:02:42Z","timestamp":1638871362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Amputation of a type II diabetic patient with cutaneous leishmaniasis due to Leishmania major"],"prefix":"10.1186","volume":"21","author":[{"given":"Arezki","family":"Izri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Bendjaballah-Laliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihcene Kherachi","family":"Djenad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoubir","family":"Harrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-9836","authenticated-orcid":false,"given":"Mohammad","family":"Akhoundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"6909_CR1","doi-asserted-by":"publisher","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","volume":"10","author":"M Akhoundi","year":"2016","unstructured":"Akhoundi M, Kuhls K, Cannet A, et al. A historical overview of the classification, evolution, and dispersion of Leishmania Parasites and Sandflies. PLoS Negl Trop Dis. 2016;10:e0004349.","journal-title":"PLoS Negl Trop Dis"},{"key":"6909_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","volume":"57","author":"M Akhoundi","year":"2017","unstructured":"Akhoundi M, Downing T, Vot\u00fdpka J, et al. Leishmania infections: molecular targets and diagnosis. Mol Aspects Med. 2017;57:1\u201329.","journal-title":"Mol Aspects Med"},{"key":"6909_CR3","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLos One. 2012;7:5671.","journal-title":"PLos One"},{"key":"6909_CR4","doi-asserted-by":"publisher","first-page":"e0006310","DOI":"10.1371\/journal.pntd.0006310","volume":"12","author":"N Eddaikra","year":"2018","unstructured":"Eddaikra N, Ait-Oudhia K, Kherrachi I, et al. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria. PLoS Negl Trop Dis. 2018;12:e0006310.","journal-title":"PLoS Negl Trop Dis"},{"key":"6909_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3201\/eid2003.13-1152","volume":"20","author":"A Izri","year":"2014","unstructured":"Izri A, Bendjaballah A, Andriantsoanirina V, et al. Cutaneous leishmaniasis caused by Leishmania killicki,\u00a0Algeria. Emerg Infect Dis. 2014;20:502\u20134.","journal-title":"Emerg Infect Dis"},{"key":"6909_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/pathogens10030267","volume":"10","author":"A Izri","year":"2021","unstructured":"Izri A, Bendjaballah-Laliam A, Sereno D, et al. Updates on geographical dispersion of Leishmania parasites causing cutaneous affections in Algeria. Pathogens. 2021;10:267.","journal-title":"Pathogens"},{"key":"6909_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.actatropica.2013.07.017","volume":"128","author":"K Benallal","year":"2013","unstructured":"Benallal K, Gassen B, Bouiba L, et al. Entomological investigation following the resurgence of human visceral leishmaniasis in southern Algeria. Acta Tropica. 2013;128:518\u201323.","journal-title":"Acta Tropica"},{"key":"6909_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0732-8893(03)00093-2","volume":"47","author":"G Sch\u00f6nian","year":"2003","unstructured":"Sch\u00f6nian G, Nasereddin A, Dinse N, et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diag Microbiol Infect. 2003;47:349\u201358.","journal-title":"Diag Microbiol Infect"},{"key":"6909_CR9","first-page":"1455","volume":"69","author":"WH Markle","year":"2004","unstructured":"Markle WH, Makhoul K. Cutaneous leishmaniasis: recognition and treatment. Am Fam Physician. 2004;69:1455\u201360.","journal-title":"Am Fam Physician"},{"key":"6909_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4103\/0022-3859.928","volume":"49","author":"NC Hepburn","year":"2003","unstructured":"Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med. 2003;49:50\u20134.","journal-title":"J Postgrad Med"},{"key":"6909_CR11","first-page":"19","volume":"1","author":"F Niksolat","year":"2020","unstructured":"Niksolat F, Tabaripour R, Davoodi L, et al. First Autochthonous Case of Emerged Zoonotic Cutaneous Leishmaniasis in Mazandaran Province, Northern Iran: kDNA-PCR Evidence Base. Infect Disord Drug Targets. 2020;1:19.","journal-title":"Infect Disord Drug Targets"},{"key":"6909_CR12","first-page":"2","volume":"124","author":"VP Santos","year":"2006","unstructured":"Santos VP, da Silveira DR, Caffaro RA. Risk factors for primary major amputation in diabetic patients. Sao Paulo Med J. 2006;124:2.","journal-title":"Sao Paulo Med J"},{"key":"6909_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0035-9203(96)90410-1","volume":"90","author":"Z Harrat","year":"1996","unstructured":"Harrat Z, Pratlong F, Belazzoug S, et al. Leishmania infantum and L. major in Algeria. Trans R Soc Trop Med Hyg. 1996;90:625\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6909_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.annder.2012.05.013","volume":"139","author":"S Chiheb","year":"2012","unstructured":"Chiheb S, Oudrhiri L, Zouhair K, et al. Leishmanioses cutan\u00e9es d\u2019aspect clinique inhabituel chez trois patients diab\u00e9tiques [Unusual clinical presentation of cutaneous leishmaniasis in three diabetic patients]. Ann Dermatol Venereol. 2012;139:542\u20135.","journal-title":"Ann Dermatol Venereol"},{"key":"6909_CR15","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1016\/j.annder.2017.09.487","volume":"144","author":"MO Ait Si Ali","year":"2017","unstructured":"Ait Si Ali MO, Khelfaoui A, Boudene F, et al. Leishmaniose cutan\u00e9e zost\u00e9riforme r\u00e9v\u00e9lant un diab\u00e8te de type 2: \u00e0 propos d\u2019un cas. Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie. 2017;144:S293.","journal-title":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"},{"key":"6909_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/14656566.2015.973850","volume":"16","author":"S Sundar","year":"2015","unstructured":"Sundar S, Chakravarty J. An update on pharmacotherapy for leishmaniasis. Expert Opin Pharmacother. 2015;16:237\u201352.","journal-title":"Expert Opin Pharmacother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06909-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:06:05Z","timestamp":1638871565000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06909-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6909"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06909-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"8 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Avicenne Hospital, France (Project identification code: 95\/99\/AVC\/ESA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent was provided and signed by the patient, including the authorization for publishing the clinical information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1227"}}